I know they will be well rewarded by their decision to take low salaries, but large stock options, I just wasn't sure if the option was a fixed number, or dependent on the price. If you're correct, and I certainly think you are, their incentive is certainly to build price, but I suspect they want to do it right, rather than rapidly, and I'm happy with that.

As an investor, I'd certainly like to see more information, but if they really believe that not doing things like putting trial protocols in the clinical trials database is in our best long term interest, I can live with it.

I believe their will be a time in the future when they'll be far more open about what they're developing. I look forward to that because by then I believe we'll see some days where the share price will increase more than our price is today. Of course we'll also have down days, but I believe their will be far more up days to celebrate. I think the next opportunity they have to open up a bit is with their Annual Report, but I don't know that they'll do it. We should know by the end of the month.

Gary